<VariationArchive VariationID="1444725" VariationName="NM_001128178.3(NPHP1):c.1130del (p.Lys377fs)" VariationType="Deletion" Accession="VCV001444725" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-17" DateCreated="2022-03-28" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1384815" VariationID="1444725">
      <GeneList>
        <Gene Symbol="LOC126806306" FullName="P300/CBP strongly-dependent group 1 enhancer GRCh37_chr2:110906815-110908014" GeneID="126806306" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="110149238" stop="110150437" display_start="110149238" display_stop="110150437" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="NPHP1" FullName="nephrocystin 1" GeneID="4867" HGNC_ID="HGNC:7905" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="110123348" stop="110205013" display_start="110123348" display_stop="110205013" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="110880912" stop="110962638" display_start="110880912" display_stop="110962638" Strand="-" />
          </Location>
          <OMIM>607100</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001128178.3(NPHP1):c.1130del (p.Lys377fs)</Name>
      <CanonicalSPDI>NC_000002.12:110150209:TTTTT:TTTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="110150210" stop="110150210" display_start="110150210" display_stop="110150210" variantLength="1" positionVCF="110150209" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="110907787" stop="110907787" display_start="110907787" display_stop="110907787" variantLength="1" positionVCF="110907786" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K377fs</ProteinChange>
      <ProteinChange>K432fs</ProteinChange>
      <ProteinChange>K376fs</ProteinChange>
      <ProteinChange>K314fs</ProteinChange>
      <ProteinChange>K433fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.110907791del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.110907791del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.110150214del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.110150214del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008287.1" sequenceAccession="NG_008287" sequenceVersion="1" change="g.59853del">
            <Expression>NG_008287.1:g.59853del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000272.5" sequenceAccession="NM_000272" sequenceVersion="5" change="c.1298del">
            <Expression>NM_000272.5:c.1298del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000263.2" sequenceAccession="NP_000263" sequenceVersion="2" change="p.Lys433fs">
            <Expression>NP_000263.2:p.Lys433fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128178.3" sequenceAccession="NM_001128178" sequenceVersion="3" change="c.1130del" MANESelect="true">
            <Expression>NM_001128178.3:c.1130del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121650.1" sequenceAccession="NP_001121650" sequenceVersion="1" change="p.Lys377fs">
            <Expression>NP_001121650.1:p.Lys377fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128179.3" sequenceAccession="NM_001128179" sequenceVersion="3" change="c.941del">
            <Expression>NM_001128179.3:c.941del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121651.1" sequenceAccession="NP_001121651" sequenceVersion="1" change="p.Lys314fs">
            <Expression>NP_001121651.1:p.Lys314fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374256.1" sequenceAccession="NM_001374256" sequenceVersion="1" change="c.1127del">
            <Expression>NM_001374256.1:c.1127del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361185.1" sequenceAccession="NP_001361185" sequenceVersion="1" change="p.Lys376fs">
            <Expression>NP_001361185.1:p.Lys376fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374257.1" sequenceAccession="NM_001374257" sequenceVersion="1" change="c.1130del">
            <Expression>NM_001374257.1:c.1130del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361186.1" sequenceAccession="NP_001361186" sequenceVersion="1" change="p.Lys377fs">
            <Expression>NP_001361186.1:p.Lys377fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_207181.4" sequenceAccession="NM_207181" sequenceVersion="4" change="c.1295del">
            <Expression>NM_207181.4:c.1295del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_997064.2" sequenceAccession="NP_997064" sequenceVersion="2" change="p.Lys432fs">
            <Expression>NP_997064.2:p.Lys432fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="772720024" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001128178.3(NPHP1):c.1130del (p.Lys377fs) AND Nephronophthisis" Accession="RCV001982565" Version="5">
        <ClassifiedConditionList TraitSetID="16865">
          <ClassifiedCondition DB="MedGen" ID="C0687120">Nephronophthisis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001128178.3(NPHP1):c.1130del (p.Lys377fs) AND Joubert syndrome with renal defect" Accession="RCV004571682" Version="1">
        <ClassifiedConditionList TraitSetID="913">
          <ClassifiedCondition DB="MedGen" ID="C1846790">Joubert syndrome with renal defect</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-29" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23559409</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32173348</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="16865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16739" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis</ElementValue>
                <XRef ID="72016" DB="GeneTests" />
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019005" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
                <XRef ID="204958008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">juvenile nephronophthisis</ElementValue>
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="206" />
                <XRef ID="206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C0687120" DB="MedGen" />
              <XRef ID="MONDO:0019005" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000090" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004748" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="913" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2499" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Joubert syndrome with renal anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Joubert syndrome 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Joubert syndrome with renal defect</ElementValue>
                <XRef ID="MONDO:0012308" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">JBTS4</ElementValue>
                <XRef Type="MIM" ID="609583" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NPHP1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Classic Joubert syndrome (JS) is characterized by three primary findings: A distinctive cerebellar and brain stem malformation called the molar tooth sign (MTS). Hypotonia. Developmental delays. Often these findings are accompanied by episodic tachypnea or apnea and/or atypical eye movements. In general, the breathing abnormalities improve with age, truncal ataxia develops over time, and acquisition of gross motor milestones is delayed. Cognitive abilities are variable, ranging from severe intellectual disability to normal. Additional findings can include retinal dystrophy, renal disease, ocular colobomas, occipital encephalocele, hepatic fibrosis, polydactyly, oral hamartomas, and endocrine abnormalities. Both intra- and interfamilial variation are seen.</Attribute>
                <XRef ID="NBK1325" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10169" />
                <XRef ID="10169" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301500</ID>
                <ID Source="BookShelf">NBK1325</ID>
              </Citation>
              <XRef ID="220497" DB="Orphanet" />
              <XRef ID="C1846790" DB="MedGen" />
              <XRef ID="MONDO:0012308" DB="MONDO" />
              <XRef Type="MIM" ID="609583" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4240641" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4832127|MedGen:C0687120" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002222443" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23559409</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23559409</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32173348</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys433Serfs*55) in the NPHP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHP1 are known to be pathogenic (PMID: 23559409). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1444725). This premature translational stop signal has been observed in individual(s) with clinical features of nephronophthisis (PMID: 23559409, 32173348). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs772720024, gnomAD 0.006%).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.110907787del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0687120" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9812376" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_000272.5:c.1298del|OMIM:609583" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005053638" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000272.5:c.1298del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609583" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9812376" TraitType="Disease" MappingType="XRef" MappingValue="609583" MappingRef="OMIM">
        <MedGen CUI="C1846790" Name="Joubert syndrome with renal defect" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4240641" TraitType="Disease" MappingType="XRef" MappingValue="C0687120" MappingRef="MedGen">
        <MedGen CUI="C0687120" Name="Nephronophthisis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

